Critical Care Reviews Podcast cover image

COMBAT-COVID Trial

Critical Care Reviews Podcast

00:00

Prostocyclin and Endothelialopathy: A Phase 2 Trial

We're going to discuss the combat COVID trial, Phase 2 trial published in the Blue Journal in late November. That was a randomized placebo controlled trial investigating prostocyclin in mechanically ventilated patients infected with SARS-CoV-2 and with severe endothelialopathy. We did some preliminary studies showing that the dose of one nanogram per kilo per minute had no measurable effect on the blood pressure or on the playphiate inhibition. On the contrary, we found that biomarkers reflecting endothelium health or damage were appeared to be beneficially affected by prostocyClin.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app